 | Up a level |
Journal Article
Chakupurakal, G., Garcia-Marquez, M., Shimabukuro vorn-hagen, A., Schloesser, H., Holtick, U., Scheid, C. and von Bergwelt-Baildon, M. (2015). Changes in T and B- cells in steroid refractory GvHD patients following treatment with a CD25-antibody. Bone Marrow Transplant., 50. S. S177 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Chakupurakal, G., Garcia-Marquez, M., Shimabukuro vorn-hagen, A., Schloesser, H., Holtick, U., Scheid, C. and von Bergwelt-Baildon, M. (2015). Changes in T and B- cells in steroid refractory GvHD patients following treatment with a CD25-antibody. Bone Marrow Transplant., 50. S. S177 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Fischer, R. N., George, J., Schaefer, S., Scheel, A., Schloesser, H., Vehreschild, M., von Bergwelt-Baildon, M., Nogova, L., Abdulla, D. S. Y., Michels, S., Riedel, R., Scheffler, M., Brossart, P., Engel-Riedel, W., Griesinger, F., Grohe, C., Kambartel, K., Kern, J., Kopp, H-G, Neukirchen, J., Overbeck, T. R., Panse, J., Sebastian, M., Serke, M., Wiewrodt, R., Buettner, R., Thomas, R. and Wolf, J. (2018). BIOLUMA: Biomarkers for nivolumab and evaluation of nivolumab plus ipilimumab in lung cancer. Oncol. Res. Treat., 41. S. 270 - 272. BASEL: KARGER. ISSN 2296-5262
Fischer, R. N., George, J., Scheel, A., Schloesser, H., Brossart, P., Engel-Riedel, W., Griesinger, F., Grohe, C., Kern, J. K., Panse, J., Sebastian, M., Serke, M., Wiewrodt, R., Michels, S., Nogova, L., Riedel, R., Weber, J-P., Buettner, R., Thomas, R. and Wolf, J. (2022). BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response - results from the NSCLC cohort. Ann. Oncol., 33 (7). S. S1025 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Garcia-Marquez, M., Schloesser, H., Thelen, M., Zimmer, S. and von Bergwelt-Baildon, M. (2016). Characterization of infiltrating B cells in human colorectal and kidney cancer. Oncol. Res. Treat., 39. S. 157 - 158. BASEL: KARGER. ISSN 2296-5262
Lechner, A., Schloesser, H., Rothschild, S., Thelen, M., Shimabukuro-Vornhagen, A., Beutner, D. and von Bergwelt-Baildon, M. (2016). Characterization of Tumor-associated B lymphocytes in head and neck squamous cell carcinoma. Oncol. Res. Treat., 39. S. 108 - 110. BASEL: KARGER. ISSN 2296-5262
Lehmann, J., Thelen, M., Schran, S., Preugszat, E., Wennhold, K., Garcia-Marquez, M., Lohneis, P., Loeser, H., Popp, F., Kruger, S., Boeck, S., Ormanns, S., Rudelius, M., von Bergwelt, M., Bruns, C., Quaas, A. and Schloesser, H. (2022). ORGANIZATION, FUNCTION AND GENE EXPRESSION OF TERTIARY LYMPHOID STRUCTURES IN PANCREATIC CANCER RESEMBLES LYMPHOID FOLLICLES IN SECONDARY LYMPHOID ORGANS AND THEIR ABUNDANCE IS RELATED TO SUPERIOR SURVIVAL. J. Immunother. Cancer, 10. S. A13 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
Oberbeck, S., Schrader, A., Warner, K., Jungherz, D., Crispatzu, G., von Jan, J., Chmielewski, M., Ianevski, A., Diebner, H. H., Mayer, P., Ados, A. Kondo, Wahnschaffe, L., Braun, T., Mueller, T. A., Wagle, P., Bouska, A., Neumann, T., Puetzer, S., Varghese, L., Pflug, N., Thelen, M., Makalowski, J., Riet, N., Goex, H. J. M., Rappl, G., Altmueller, J., Kotrova, M., Persigehl, T., Hopfinger, G., Hansmann, M. L., Schloesser, H., Stilgenbauer, S., Duerig, J., Mougiakakos, D., Von Bergwelt-Baildon, M., Roeder, I, Hartmann, S., Hallek, M., Moriggl, R., Brueggemann, M., Aittokallio, T., Iqbal, J., Newrzela, S., Abken, H. and Herling, M. (2020). Noncanonical effector functions of the T-memory-like T-PLL cell are shaped by cooperative TCL1A and TCR signaling. Blood, 136 (24). S. 2786 - 2803. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Quaas, A., Schloesser, H., Fuchs, H., Zander, T., Arolt, C., Scheel, A. H., Rueschoff, J., Bruns, C., Buettner, R. and Schroeder, W. . Improved Tissue Processing in Esophageal Adenocarcinoma After Ivor Lewis Esophagectomy Allows Histological Analysis of All Surgically Removed Lymph Nodes with Significant Effects on Nodal UICC Stages. Ann. Surg. Oncol.. NEW YORK: SPRINGER. ISSN 1534-4681
Schoemmel, M., Loeser, H., Kraemer, M., Wagener-Ryczek, S., Hillmer, A., Bruns, C., Thelen, M., Schroeder, W., Zander, T., Lechner, A., Buettner, R., Schloesser, H., Gebauer, F. and Quaas, A. (2021). Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus. Clin. Transl. Oncol., 23 (8). S. 1601 - 1611. CHAM: SPRINGER INT PUBL AG. ISSN 1699-3055
Schran, S., Datta, R., Persa, O., Aguilar, C., Thelen, M., Lehmann, J., Garcia-Marquez, M., Wennhold, K., Quaas, A., Bruns, C., Mauch, C., Loeser, H., Stippel, D. and Schloesser, H. (2021). T- AND B-CELL ABUNDANCE ARE REMARKABLY REDUCED IN THE IMMUNE MICROENVIRONMENT OF POST-TRANSPLANT MALIGNANCIES. J. Immunother. Cancer, 9. S. A7 - 2. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
Thelen, M., Lechner, A., Schloesser, H., Rothschild, S., Wennhold, K., Beutner, D. and von Bergwelt-Baildon, M. (2017). Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma (HNSCC). Oncol. Res. Treat., 40. S. 251 - 252. BASEL: KARGER. ISSN 2296-5262
Theurich, S., Iltgen, J., Wennhold, K., Marquez, M. Garcia, Rothschild, S., Schneider, B., Holtick, U., Thelen, M., Scheid, C., Becker, Hj, Schloesser, H., Reuter, S., Vornhagen, A. Shimabukuro and von Bergwelt-Baildon, M. (2016). THE JAK1/2 INHIBITOR RUXOLITINIB MODULATES ANTIGEN PRESENTING FUNCTIONS OF ACTIVATED PRIMARY B CELLS ON A METABOLIC LEVEL. Haematologica, 101. S. 462 - 463. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Theurich, S., Iltgen-Brebuda, J., Thelen, M., Wennhold, K., Rothschild, S., Becker, H., Schloesser, H., Shimabukuro-Vornhagen, A. and von Bergwelt-Baildon, M. (2017). Ruxolitinib modulates the antigen presenting function of activated B cells by interfering with metabolic pathways. Oncol. Res. Treat., 40. S. 262 - 263. BASEL: KARGER. ISSN 2296-5262
Theurich, S., Schlaak, M., Steguweit, H., Heukamp, L. C., Wennhold, K., Kurschat, P., Rabenhorst, A., Hartmann, K., Shimabukuro-Vornhagen, A., Schloesser, H., Holtick, U., Hallek, M., Stadler, R. and von Bergwelt-Baildon, M. (2014). Tumor infiltrating B-cells in primary cutaneous T-cell lymphoma correlate with disease progression and might represent a novel target for immunotherapy. Exp. Dermatol., 23 (3). S. E25 - 1. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0625
Theurich, S., Schlaak, M., Steguweit, H., Heukamp, L. C., Wennhold, K., Kurschat, P., Shimabukuro-Vornhagen, A., Schloesser, H., Holtick, U., Hallek, M., Stadler, R. and von Bergwelt-Baildon, M. (2014). Tumor infiltrating B-cells in primary cutaneous T-cell lymphoma correlate with disease progression and might represent a novel target for immunotherapy. Oncol. Res. Treat., 37. S. 31 - 32. BASEL: KARGER. ISSN 2296-5262
Wennhold, K., Thelen, M., Lechner, A., Schloesser, H. and von Bergwelt-Baildon, M. (2018). CD86+antigen-presenting B cells are increased in solid cancers and induce tumor antigen-specific T cell responses. Oncol. Res. Treat., 41. S. 235 - 236. BASEL: KARGER. ISSN 2296-5262
Wennhold, K., Thelen, M., Schloesser, H., Shimabukuro-Vornhagen, A. and von Bergwelt-Baildon, M. (2017). Using antigen-specific B cells to combine antibody and T cell based cancer immunotherapy. Oncol. Res. Treat., 40. S. 241 - 242. BASEL: KARGER. ISSN 2296-5262
Zimmer, S., Schloesser, H., Wennhold, K., Thelen, M., Garcia-Marquez, M. and von Bergwelt-Baildon, M. (2016). Characterization of B-cell subsets in renal cell carcinoma. Oncol. Res. Treat., 39. S. 19 - 20. BASEL: KARGER. ISSN 2296-5262